MAPK3 and cancer: In previous reports, ZMYM2-FGFR1 continuously activates the kinase domain in the C-terminal and FGFR signalling, resulting in STAT1/3 phosphorylation and the induction of diverse genes involved in cell survival and proliferation by ERK1/2 in cancer cells48–50.